Viral vectors for vascular gene therapy.

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Cardiovascular Research

Background:

• Vascular gene therapy holds significant therapeutic potential but faces challenges in optimal gene delivery methods.
• Viral vectors are highly efficient for gene transfer, making them a primary focus in vascular gene therapy research.

Purpose of the Study:

• To review the characteristics of an ideal viral vector for vascular gene therapy.
• To survey major viral vectors employed in vascular gene transfer, both in vivo and ex vivo.
• To discuss advancements in viral vectorology for clinical translation.

Main Methods:

• Review of current literature on viral vectors in vascular gene therapy.
• Analysis of adenoviral-based vectors in clinical trials for angiogenesis.
• Examination of retroviral-based vectors for ex vivo gene transfer.

Main Results:

• Viral vectors, particularly adenoviral-based ones, are actively used in clinical trials for angiogenesis.
• Retroviral-based vectors are suitable for ex vivo gene transfer applications.
• Emerging techniques like pseudotyping enhance vector specificity and efficiency.

Conclusions:

• Viral vectors are essential tools for advancing vascular gene therapy.
• Continued innovation in viral vector design is key to bridging experimental and clinical vascular gene therapy.
• Targeted delivery and improved vector characteristics will accelerate clinical adoption.